Browse studies

Find your next paid study

12 recruiting studies matching your filters

Effects of Auricular Point Acupressure for Chronic Musculoskeletal Pain in Older People With HIV: a Pilot Randomized Controlled Trial

The goal of this pilot clinical trial is to learn whether auricular point acupressure (APA) can help reduce chronic musculoskeletal pain in adults age 50 and o…

HIV (Human Immunodeficiency Virus)Pain

A Multi-Center, Single-Arm, Open-Label, Prospective, Phase 4 Study to Investigate the Safety and Efficacy of Rapidly Restarting Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Viremic and Virologically-Suppressed Male and Female HIV-Positive Patients Aged ≥18 Years Who Are Treatment-Experienced and Returning to Care After Experiencing a Treatment Interruption of ≥12 Weeks

Managing HIV well requires taking antiretroviral therapy (ART) every day, but many people living with HIV experience interruptions in their treatment. These pa…

HIV -1 InfectionHIV (Human Immunodeficiency Virus)HIV+1 more

Estimated

~$10 – $7,500

CAN Community HealthNCT07476339

Phase 1

A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of a Higher Dose of the HCMV-HIV Vaccine Candidate VIR-1388, in HCMV-seropositive Adult Participants Without HIV

This study is to test an experimental HIV Vaccine. About 12 participants, aged 18-55 years and who already have cytomegalovirus (CMV) will take part in this st…

Cytomegalovirus (CMV)HIV (Human Immunodeficiency Virus)

Estimated

~$10 – $5,625

National Institute of Allergy and Infectious Diseases (NIAID)NCT07801456

Phase 2

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of Resmetirom for the Treatment of Metabolic Dysfunction- Associated Steatotic Liver Disease (MASLD) in People Living With Human Immunodeficiency Virus (HIV)

The purpose of this research study is to test the safety and effectiveness of the study drug, resmetirom, in participants with MASLD and HIV. This is a researc…

MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseHIV (Human Immunodeficiency Virus)

Estimated

~$10 – $8,750

Naga P. ChalasaniNCT07143968

Phase 4

Vaginal Estradiol Versus Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms, Dysbiosis and Markers of Latency Reversal in Menopausal Women Living With HIV

This is a research study about the effects of vaginal estradiol compared to moisturizer on vaginal symptoms of menopause and the microbiome in women with HIV. …

Menopausal ComplaintsVaginal AtrophyGenitourinary Symptoms+4 more

Estimated

~$10 – $6,250

Albert Einstein College of MedicineNCT07526948

Stimulant and Polysubstance Use, Inflammation, and Sex Effects on Myocardial Disease in HIV (SPISE)

This observational research study is studying how substance use impacts scarring and inflammation of the heart. This study involves one study visit for a cardi…

HIV (Human Immunodeficiency Virus)

Estimated

~$10 – $675

University of California, San FranciscoNCT07461350

Phase 2

A Feasibility and Acceptability Study Testing Two Types of Smell Exposure Interventions in Middle-Aged Older Adults With HIV

The goal of this study is to examine two types of olfactory interventions (conventional olfactory training vs scented marker training) in adults with HIV. The…

HIV (Human Immunodeficiency Virus)

Estimated

~$10 – $6,250

University of Alabama at BirminghamNCT07221123

Observational

Evaluating a Clinical Decision Support Tool for Antiretroviral Therapy Optimization

This study is testing software designed to help healthcare providers choose the best HIV treatment combinations for their patients. HIV medicines, known as ant…

HIV (Human Immunodeficiency Virus)Clinical Decision Support System (CDSS)Antiretroviral Therapy, Highly Active+4 more

Estimated

~$10 – $6,250

Keck School of Medicine of USCNCT07219862

Observational

Efficacy of a Community-based PrEP Uptake Intervention for People Who Inject Drugs (PWID) in the US Northeast

This randomized controlled trial will test the efficacy of "PrEP for Health," a behavioral intervention to improve the use of antiretroviral pre-exposure proph…

Substance DependenceHIV (Human Immunodeficiency Virus)

Estimated

~$10 – $6,250

Brown UniversityNCT04430257

Phase 1

IGHID 12430 - Deliver-02 - A Phase 1, Open Label, Randomized Study To Evaluate The Safety And Tolerability Of MGD014 And MGD020 With A Latency Reversal Agent Versus Temporary Treatment Interruption In Persons With HIV-1 On Antiretroviral Therapy

This research study aims to find out how safe and well tolerated the experimental study drugs are when given to persons with HIV (PWH) taking antiretroviral th…

HIV (Human Immunodeficiency Virus)

Estimated

~$10 – $6,250

University of North Carolina, Chapel HillNCT07217379

Phase 2

A Single-Arm, Open-Label Clinical Phase II Trial of the Safety and Immunogenicity of PDS0101 in People Living With HIV

This study is testing the immunotherapeutic agent, PDS0101, in adults living with HIV who are also infected with human papillomavirus (HPV) type 16. The purpos…

HPV Associated CancersHIV (Human Immunodeficiency Virus)Anal Cancer+2 more

Estimated

~$10 – $6,250

Weill Medical College of Cornell UniversityNCT07090174

Assessing Performance of a Hepatitis C Emergency Department (HepC-EnD) Screening Tool: IT Integration Process for Electronic Health Record System

The goal of this observational study is to develop, implement, and evaluate a machine learning algorithm-based Hepatitis C Emergency Department (HepC-EnD) scre…

Hepatitis C Virus (HCV)Hepatitis C Virus (HCV) InfectionHIV (Human Immunodeficiency Virus)

Estimated

~$10 – $750

University of FloridaNCT07406490